Silybin A水飞蓟宾 A,22888-70-6

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Silybin A

CAS No. : 22888-70-6

MCE 国际站：Silybin A

产品活性：Silybin A (Silibinin A) 为抗癌和化疗预防化合物，能抑制细胞增殖和迁移。

研究领域：Autophagy  |  Metabolic Enzyme/Protease  |  Immunology/Inflammation  |  NF-κB

作用靶点：Autophagy  |  Reactive Oxygen Species

In Vitro: Silybin A (Silybin) significantly induced the expression of the non-steroidal anti-inflammatory drug-activated gene-1 (NAG-1) in both p53 wild-type and p53-null cancer cell lines.
Silybin A (Silybin) induced cell death in human breast cancer cell lines MCF7 and MDA-MB-231.
Silybin A (Silybin) treatment resulted in a dose- and time-dependent inhibition of HCC cell viability.
Silybin A (Silybin) treatment decreased the expression of the Notch1 intracellular domain (NICD), RBP-Jκ, and Hes1 proteins, upregulated the apoptosis pathway-related protein Bax, and downregulated Bcl2, survivin, and cyclin D1.

In Vivo: Topical application of Silybin A (Silibinin A) at the dose of 9 mg/mouse effectively suppressed oxidative stress and deregulated activation of inflammatory mediators and tumorigenesis.
The kidney cortex of vehicle-treated control OVE26 mice displayed greater Nox4 expression and twice as much superoxide production than cortex of silybin-treated mice. The glomeruli of control OVE26 mice displayed 35% podocyte drop out that was not present in the silybin-treated mice.

相关产品：Natural Product Library Plus  |  Drug Repurposing Compound Library Plus  |  FDA-Approved Drug Library Plus  |  FDA-Approved Drug Library Mini  |  Bioactive Compound Library Plus  |  Immunology/Inflammation Compound Library  |  Metabolism/Protease Compound Library  |  NF-κB Signaling Compound Library  |  Stem Cell Signaling Compound Library  |  Natural Product Library  |  FDA-Approved Drug Library  |  Anti-Cancer Compound Library  |  Antiviral Compound Library  |  Autophagy Compound Library  |  Anti-Aging Compound Library  |  Drug Repurposing Compound Library  |  Antioxidant Compound Library  |  Lipid Compound Library  |  Oxygen Sensing Compound Library  |  Ferroptosis Compound Library  |  Anti-COVID-19 Compound Library  |  NMPA-Approved Drug Library  |  Medicine Food Homology Compound Library  |  Pyroptosis Compound Library  |  Traditional Chinese Medicine Active Compound Library  |  FDA Approved & Pharmacopeial Drug Library  |  Flavonoids Library  |  Anti-Breast Cancer Compound Library  |  Mitochondria-Targeted Compound Library  |  Anti-Cancer Natural Product Library  |  Chemotherapy Drug Library  |  Anti-inflammatory Traditional Chinese Medicine Active Compound Library  |  Plant-Sourced Natural Product Library  |  FDA-Approved Anticancer Drug Library  |  Human Metabolite Library  |  Off-patent Drug Library  |  Cell Death Library  |  FDA-Approved Traditional Chinese Medicine Active Compound Library  |  Acetylcysteine  |  H2DCFDA  |  Deferoxamine mesylate  |  Elesclomol  |  Quercetin  |  MitoSOX Red  |  L-Ascorbic acid  |  Mito-TEMPO  |  Mitoquinone mesylate  |  L-Glutathione reduced  |  Trolox  |  Zinc Protoporphyrin  |  FX-11  |  Dimethyl fumarate  |  Diphenyleneiodonium chloride  |  Berberine chloride  |  Urolithin A  |  TPEN  |  Sodium dichloroacetate  |  Tempol  |  2-Methoxyestradiol  |  GSK2795039  |  α-Vitamin E  |  Ciprofloxacin  |  Trabectedin  |  Coenzyme Q10  |  Piperlongumine  |  Chlorogenic acid  |  Ellagic acid  |  L-Ascorbic acid 2-phosphate trisodium

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds